These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12135006)

  • 1. Hepatitis A vaccination in patients with chronic liver disease: to screen or not to screen?
    Rothstein KD
    Am J Gastroenterol; 2002 Jul; 97(7):1590-3. PubMed ID: 12135006
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: hepatitis vaccination in patients with chronic liver disease.
    Reiss G; Keeffe EB
    Aliment Pharmacol Ther; 2004 Apr; 19(7):715-27. PubMed ID: 15043512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: a prospective cost analysis.
    Duncan M; Hirota WK; Tsuchida A
    Am J Gastroenterol; 2002 Jul; 97(7):1792-5. PubMed ID: 12135037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical inquiries: Who should get hepatitis A vaccination?
    Brown R; Cable K; Sams R
    J Fam Pract; 2005 Jul; 54(7):624-5; discussion 624. PubMed ID: 16009092
    [No Abstract]   [Full Text] [Related]  

  • 5. Overcoming obstacles to immunization in patients with chronic liver disease.
    Bockhold K; Riely CA; Jeffreys C
    Am J Med; 2005 Oct; 118 Suppl 10A():40S-45S. PubMed ID: 16271540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against hepatitis A in children].
    Gendrel D
    Arch Pediatr; 2004 Nov; 11(11):1360-6. PubMed ID: 15519837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease.
    El-Karaksy H; El-Sayed R; El-Raziky M; El-Koofy N; Mansour S
    East Mediterr Health J; 2008; 14(4):804-9. PubMed ID: 19166163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New target groups for vaccination against hepatitis A: homosexual men, addicts and persons with chronic liver disease].
    Iwarson S
    Lakartidningen; 1998 Apr; 95(16):1750-3. PubMed ID: 9599479
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis A and hepatitis B vaccination of patients with chronic liver disease.
    Bell BP
    Acta Gastroenterol Belg; 2000; 63(4):359-63. PubMed ID: 11233518
    [No Abstract]   [Full Text] [Related]  

  • 11. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine vaccination of HIV-infected patients against hepatitis A: should we discriminate before vaccination according to ethnicity?
    Górgolas M; Rivas P; Guerrero ML
    Clin Infect Dis; 2005 Jul; 41(2):272-3. PubMed ID: 15983933
    [No Abstract]   [Full Text] [Related]  

  • 15. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India.
    Dhotial A; Kapoor D; Kumar N
    Trop Gastroenterol; 2002; 23(4):170-1. PubMed ID: 12833702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination.
    Keeffe EB
    Am J Med; 2005 Oct; 118 Suppl 10A():21S-27S. PubMed ID: 16271537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs.
    Deneke MG; Arguedas MR
    Expert Rev Vaccines; 2003 Oct; 2(5):661-72. PubMed ID: 14711327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing acute liver disease in patients with chronic liver disease.
    Sjogren MH
    Hepatology; 1998 Mar; 27(3):887-8. PubMed ID: 9500724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.